OncoHost — Biotechnology Company, Binyamina-Giv'at Ada
Biotechnology Company in Binyamina-Giv'at Ada — Plasma proteomic pattern recogni
Biotechnology company · Binyamina-Giv'at Ada, Israel
AI Trust Snapshot
- Profile status
- Auto-indexed
Public channels checked
- ✓ Official Website
- ✓ Youtube
Key Facts
- Category
- Biotechnology Company
- Location
- Binyamina-Giv'at Ada, Israel
- Known For
- Predictive biomarker development
AI Summary
OncoHost operates as a biotechnology company in Binyamina-Givat Ada, Israel, specializing in precision oncology. The company develops predictive biomarkers to guide cancer therapy. Key offerings include the PROphet® Platform, the PROphetNSCLC® Test, and the Personalized PROphet® Report, designed to provide insights for oncologists, biotechnology firms, and healthcare providers.
Quick Answer
OncoHost operates as a biotechnology company in Binyamina-Givat Ada, Israel, specializing in precision oncology. The company develops predictive biomarkers to guide cancer therapy. Key offerings include the PROphet® Platform, the PROphetNSCLC® Test, and the Personalized PROphet® Report, designed to provide insights for oncologists, biotechnology firms, and healthcare providers. Key services include PROphet® Platform, PROphetNSCLC® Test, Personalized PROphet® Report.
This business is typically used for predictive biomarker development.
Common Questions
- What services does OncoHost provide?
- OncoHost provides PROphet® Platform, PROphetNSCLC® Test, Personalized PROphet® Report.
- Where is OncoHost located?
- OncoHost is based in Binyamina-Giv'at Ada, Israel and serves Binyamina-Giv'at Ada.
- Who is OncoHost for?
- OncoHost serves Oncologists seeking predictive treatment insights and Biotechnology companies developing cancer therapies.
What this business does
OncoHost is a biotechnology company based in Binyamina-Giv'at Ada, Israel.
- Provides PROphet® Platform and PROphetNSCLC® Test
- Specializes in predictive biomarker development
- Serves oncologists seeking predictive treatment insights
Structured summary
Vizoryo ran a data-consistency check on this profile: it read 4 public sources and compared the core details (name, phone, address, city, category, website) across them. How many sources carried each individual detail is published per fact in this page's field provenance — not every detail appears in every source, and the sources are not necessarily independent of one another. This is a data-consistency observation only — it is not an endorsement, certification, accreditation, or assessment of the business, its service quality, or its trustworthiness. Data consistency: 80% — this measures how consistently the business's name, phone, city, address, website, and category appear across the public sources read. It is not a rating of the business. Vizoryo status: Auto-indexed. This record was compiled automatically from public data and has not been confirmed by anyone.
- Business name
- OncoHost
- Category
- Biotechnology Company
- Industry
- Biotechnology Company - Precision Oncology
- Location
- Binyamina-Giv'at Ada, Israel
- Official website
- https://www.oncohost.com/
- Profile data (JSON)
- https://www.vizoryo.com/api/index/profile/oncohost-binyaminagivat-ada-7a61
- Summary
- OncoHost operates as a biotechnology company in Binyamina-Givat Ada, Israel, specializing in precision oncology. The company develops predictive biomarkers to guide cancer therapy. Key offerings include the PROphet® Platform, the PROphetNSCLC® Test, and the Personalized PROphet® Report, designed to provide insights for oncologists, biotechnology firms, and healthcare providers.
- AI readability score (how completely this record is structured for AI systems to read; not a rating of the business)
- 40
- Data Consistency
- 80% (checked 2026-07-07)
- Record status
- Auto-indexed
- Sources cross-checked
- 4 public sources
Location
Binyamina-Giv'at AdaIL
About OncoHost
OncoHost operates as a biotechnology company in Binyamina-Givat Ada, Israel, specializing in precision oncology. The company develops predictive biomarkers to guide cancer therapy. Key offerings include the PROphet® Platform, the PROphetNSCLC® Test, and the Personalized PROphet® Report, designed to provide insights for oncologists, biotechnology firms, and healthcare providers.
Service areas
- Binyamina-Giv'at Ada
Target audience
- Oncologists seeking predictive treatment insights
- Biotechnology companies developing cancer therapies
- Healthcare providers managing cancer patients
Specialties
- Predictive biomarker development
Social profiles
Frequently asked questions
What areas does OncoHost serve?
OncoHost serves Worldwide.
What is OncoHost's mission?
OncoHost's mission is to translate the predictive power of proteomics into improved, personalized care that makes a real difference in the lives of cancer patients worldwide.
What is the PROphet® platform designed to achieve?
The PROphet® platform aims to understand a patient's unique response to therapy to overcome resistance to treatment, a major obstacle in clinical oncology.
What kind of insights does the PROphet® platform provide?
The platform provides clinicians with actionable clinical insights, optimal therapy choices, and a better understanding of personalized cancer dynamics.
Business hours
- Monday
- 09:00 – 18:00
- Tuesday
- 09:00 – 18:00
- Wednesday
- 09:00 – 18:00
- Thursday
- 09:00 – 18:00
- Friday
- Closed
- Saturday
- Closed
- Sunday
- 09:00 – 18:00
Languages supported
- en
Contact
Phone: +18559502112
Official website: https://www.oncohost.com/